Scholars Central

Research articlePublished 1 Jun 2017

Importance of p53, bcl-2, p21WAF1 and PCNA positivities in renal angiomyolipomas

Authors: Metin Budak, Omer Yalcin, Ufuk Usta, Burcu Tokuc

Biomedical Research

Volume 28 · Issue 10 · Pages 4696–4702

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Angiomyolipomas are tumors of the kidneys which are often benign in character with a potential for malignant transformation. The benign-malign distinction in these tumors can be made only with clinical follow-up as they exhibit the same microscopic appearance. In the present study, immunohistochemical investigation has been performed for p53, p21WAF1, PCNA and bcl-2, which may be markers for the histological distinction of benign and malignant cases. The p53, p21WAF1, PCNA and bcl-2 investigations in 10 tumor tissues with AML revealed significantly higher p53 positivity in 3 patients. The clinical follow-up of these three patients showed malignant progression. In conclusion, we believe that p53 positivity may be an appropriate marker for the benign-malign distinction in AML tumors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Metin Budak”
  • BylineArticles whose byline prints “Omer Yalcin”
  • BylineArticles whose byline prints “Ufuk Usta”
  • BylineArticles whose byline prints “Burcu Tokuc”